• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

For many years, bleeding has been perceived as an unavoidable consequence of strategies
aimed at reducing thrombotic complications in patients undergoing percutaneous coronary …

BACKGROUND: The benefit: risk profile of bivalirudin versus heparin anticoagulation in
patients with non–ST-segment–elevation myocardial infarction undergoing percutaneous …

BACKGROUND: Radial artery access for coronary angiography or percutaneous coronary
intervention (PCI) reduces the risk of death, bleeding, and vascular complications and is …

Data comparing outcomes of distal radial (DR) and traditional radial (TR) access of coronary
angiography and percutaneous coronary intervention (PCI) are limited. Online databases …

Introduction In patients with acute coronary syndrome (ACS), the ischemic benefit of
antithrombotic treatment is counterbalanced by the risk of bleeding. The recognition that …

Since the beginning of interventional cardiology and for decades, the femoral artery has
been the access of choice for both diagnostic and interventional endovascular procedures …

The aim of this study was to assess the immediate and medium-term (3 months) results of
the safety and efficacy of distal radial access (DRA) in coronary interventions compared with …

In the last decades, radial access, as an alternative to femoral access, has rapidly evolved
and emerged as the preferred vascular access for coronary angiography and percutaneous …

Despite current advancements in chemotherapy, immunotherapy and targeted treatments,
the potential for major adverse cardiovascular events, regardless of previous cardiac history …